Literature DB >> 27517370

Histogram analysis of apparent diffusion coefficients after neoadjuvant chemotherapy in breast cancer.

Yun Ju Kim1, Sung Hun Kim2, Ah Won Lee3, Min-Sun Jin3, Bong Joo Kang4, Byung Joo Song5.   

Abstract

PURPOSE: To evaluate the changes in the apparent diffusion coefficient (ADC) histogram during neoadjuvant chemotherapy (NAC) for breast cancer, and to compare the observed changes in pathologically verified responders and non-responders.
MATERIALS AND METHODS: Sixty-two patients received NAC followed by surgery. Responders were defined by a tumor cell reduction of at least 30 % using the Miller-Payne grading system. All the patients underwent 3T magnetic resonance with diffusion-weighted imaging (b values of 0 and 750 s/mm2) before the NAC and after the completion of two cycles of NAC.
RESULTS: Mean, minimum, 10th, 25th, 50th, and 75th percentile of ADCs significantly increased after NAC and maximum ADC significantly decreased. Skewness became less positive and kurtosis decreased. A tendential, although not statistically significant, higher increase in mean, minimum, 10th, 25th, 50th, 75th, and 90th percentiles of ADCs was observed in responders in comparison with non-responders.
CONCLUSION: ADC histogram analysis quantitatively demonstrates the alterations during the treatment course.

Entities:  

Keywords:  Breast neoplasms; Diffusion; Magnetic resonance imaging; Neoadjuvant therapy

Mesh:

Substances:

Year:  2016        PMID: 27517370     DOI: 10.1007/s11604-016-0570-2

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  32 in total

1.  MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?

Authors:  Kandace P McGuire; Jorge Toro-Burguete; Hang Dang; Jessica Young; Atilla Soran; Margarita Zuley; Rohit Bhargava; Marguerite Bonaventura; Ronald Johnson; Gretchen Ahrendt
Journal:  Ann Surg Oncol       Date:  2011-09-27       Impact factor: 5.344

2.  Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T.

Authors:  Wolfgang Bogner; Katja Pinker-Domenig; Hubert Bickel; Marek Chmelik; Michael Weber; Thomas H Helbich; Siegfried Trattnig; Stephan Gruber
Journal:  Radiology       Date:  2012-04       Impact factor: 11.105

3.  Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

Authors:  Yusuhn Kang; Seung Hong Choi; Young-Jae Kim; Kwang Gi Kim; Chul-Ho Sohn; Ji-Hoon Kim; Tae Jin Yun; Kee-Hyun Chang
Journal:  Radiology       Date:  2011-10-03       Impact factor: 11.105

4.  A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival.

Authors:  Keith N Ogston; Iain D Miller; Simon Payne; Andrew W Hutcheon; Tarun K Sarkar; Ian Smith; A Schofield; Steven D Heys
Journal:  Breast       Date:  2003-10       Impact factor: 4.380

5.  Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.

Authors:  Lori R Arlinghaus; Xia Li; Mia Levy; David Smith; E Brian Welch; John C Gore; Thomas E Yankeelov
Journal:  J Oncol       Date:  2010-09-29       Impact factor: 4.375

Review 6.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

7.  Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations.

Authors:  Line B Nilsen; Anne Fangberget; Oliver Geier; Therese Seierstad
Journal:  Eur Radiol       Date:  2012-10-31       Impact factor: 5.315

8.  Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer.

Authors:  P Chollet; S Amat; H Cure; M de Latour; G Le Bouedec; M-A Mouret-Reynier; J-P Ferriere; J-L Achard; J Dauplat; F Penault-Llorca
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

Review 9.  Improving tumour heterogeneity MRI assessment with histograms.

Authors:  N Just
Journal:  Br J Cancer       Date:  2014-09-30       Impact factor: 7.640

10.  Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images.

Authors:  Kate Downey; Sophie F Riches; Veronica A Morgan; Sharon L Giles; Ayoma D Attygalle; Tom E Ind; Desmond P J Barton; John H Shepherd; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

View more
  10 in total

1.  Differentiation between solitary fibrous tumors and schwannomas of the head and neck: an apparent diffusion coefficient histogram analysis.

Authors:  Natsuko Kunimatsu; Akira Kunimatsu; Koki Miura; Ichiro Mori; Shigeru Nawano
Journal:  Dentomaxillofac Radiol       Date:  2019-01-10       Impact factor: 2.419

2.  q-Space Imaging Yields a Higher Effect Gradient to Assess Cellularity than Conventional Diffusion-weighted Imaging Methods at 3.0 T: A Pilot Study with Freshly Excised Whole-Breast Tumors.

Authors:  Nicholas Senn; Yazan Masannat; Ehab Husain; Bernard Siow; Steven D Heys; Jiabao He
Journal:  Radiol Imaging Cancer       Date:  2019-09-27

3.  Radiomic Analysis of Tumour Heterogeneity Using MRI in Head and Neck Cancer Following Chemoradiotherapy: A Feasibility Study.

Authors:  Amrita Guha; Mustafa Anjari; Gary Cook; Vicky Goh; Steve Connor
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

4.  Whole-lesion histogram analysis of apparent diffusion coefficient for the assessment of non-mass enhancement lesions on breast MRI.

Authors:  Natsuko Kunimatsu; Akira Kunimatsu; Yoshihiro Uchida; Ichiro Mori; Shigeru Kiryu
Journal:  J Clin Imaging Sci       Date:  2022-03-23

5.  Using the apparent diffusion coefficient histogram analysis to predict response to neoadjuvant chemotherapy in patients with breast cancer: comparison among three region of interest selection methods.

Authors:  Xiaochuan Geng; Dandan Zhang; Shiteng Suo; Jie Chen; Fang Cheng; Kebei Zhang; Qing Zhang; Lan Li; Yang Lu; Jia Hua; Zhiguo Zhuang
Journal:  Ann Transl Med       Date:  2022-03

Review 6.  Diagnostic Performance of Diffusion Kurtosis Imaging for Benign and Malignant Breast Lesions: A Systematic Review and Meta-Analysis.

Authors:  Hongyu Gu; Wenjing Cui; Song Luo; Xiaoyi Deng
Journal:  Appl Bionics Biomech       Date:  2022-06-09       Impact factor: 1.664

7.  SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.

Authors:  Xu Chen; Ya-Wen Wang; Peng Gao
Journal:  J Exp Clin Cancer Res       Date:  2018-05-09

8.  Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer.

Authors:  Alexey Surov; Andreas Wienke; Hans Jonas Meyer
Journal:  Breast       Date:  2020-06-26       Impact factor: 4.380

9.  Phased-array combination of 2D MRS for lipid composition quantification in patients with breast cancer.

Authors:  Vasiliki Mallikourti; Sai Man Cheung; Tanja Gagliardi; Nicholas Senn; Yazan Masannat; Trevor McGoldrick; Ravi Sharma; Steven D Heys; Jiabao He
Journal:  Sci Rep       Date:  2020-11-18       Impact factor: 4.379

Review 10.  Diffusion-weighted imaging of the breast: current status as an imaging biomarker and future role.

Authors:  Julia Camps-Herrero
Journal:  BJR Open       Date:  2019-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.